Skip to main content
. 2020 Mar 17;26(5-6):279–291. doi: 10.1089/ten.tea.2019.0237

FIG. 1.

FIG. 1.

3D printing of PCL/HAp scaffolds and the in situ monitoring of the geometrical outcome. (a) Schematic of PCL/HAp printing and microstructure of interspersed HAp in the thermoplastic PCL. (b) Print setup of the bioplotter used in the study and the location of the camera for in situ monitoring of the printing process. (c) Layer by layer images generated through in situ monitoring. (d) A representative image of a 3D printed PCL/HAp scaffold with clinically relevant dimensions. 3D, three dimensional; PCL, poly(caprolactone); HAp, hydroxyapatite.